SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-19-000233
Filing Date
2019-08-08
Accepted
2019-08-08 17:21:25
Documents
13
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF AUGUST, 2019 imv6kq2.htm 6-K 5959
2 INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDED JUNE 30, 2019 exhibit99-1.htm EX-99.1 219457
3 MANAGEMENT DISCUSSION AND ANALYSIS FOR THE PERIOD ENDED JUNE 30, 2019 exhibit99-2.htm EX-99.2 170886
4 CEO CERTIFICATION exhibit99-3.htm EX-99.3 8818
5 CFO CERTIFICATION exhibit99-4.htm EX-99.4 8833
6 exhibit99-1x1x1.jpg GRAPHIC 18708
7 exhibit99-2x1x1.jpg GRAPHIC 18469
8 exhibit99-2x8x1.jpg GRAPHIC 57746
9 exhibit99-2x8x2.jpg GRAPHIC 12989
10 exhibit99-2x9x1.jpg GRAPHIC 106698
11 exhibit99-2x10x1.jpg GRAPHIC 57230
12 exhibit99-2x11x1.jpg GRAPHIC 76979
13 exhibit99-2x24x1.jpg GRAPHIC 47909
  Complete submission text file 0001176256-19-000233.txt   962440
Mailing Address 1344 SUMMER STREET, SUITE 412 HALIFAX A5 B3H 0A8
Business Address 1344 SUMMER STREET, SUITE 412 HALIFAX A5 B3H 0A8 9024921819
IMV Inc. (Filer) CIK: 0001734768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2Q | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38480 | Film No.: 191010651
SIC: 2834 Pharmaceutical Preparations